Who We Are
Tattarang is one of Australia’s largest private investment groups and is owned by the Forrest family.
Our investment portfolio spans across agri-food, energy, resources, property, hospitality, and sport.
The group is made up of six business divisions: Fiveight, Harvest Road, SFM Marine, Squadron Energy, Wyloo Metals and Z1Z.
We believe in investing for growth and pursue opportunities in both the listed and unlisted space with a long term investment horizon.
Courage & Determination
We never, ever give up.
We take action and encourage our team.
We are positive and energetic.
Care for your workmates.
Think of ways we can do things better, faster, cheaper, safer.
Always be on the lookout for better ways.
We show vulnerability in leadership.
Do what you say you’re going to do.
The group’s name and logo pays tribute to a fiery stallion of the same name that was cherished at the Forrest family’s Minderoo Station in the 1950s.
It signifies the unique bond of trust that is formed between a rider and their horse and the seriousness with which each party invests in caring for and protecting the other.
Dr Andrew Forrest AO is Chairman of Fortescue Metals Group, a global leader in the iron ore industry, which he founded in 2003. Tattarang holds a 36 per cent shareholding in Fortescue Metals Group.
Dr Forrest is Chairman of Minderoo Foundation and Nicola Forrest AO is the Co-chair.
“If we combine ethical business practices with macro philanthropy, we create an overwhelmingly powerful force for common good.”
– Andrew Forrest
We are agile in the way we work and pride ourselves on robust thinking and quick decision making. Our team is constantly looking for opportunities to challenge norms within an industry sector.
Swoop is an independent Australian-owned telecommunication company focussed on delivering effortless, fast and reliable fixed wireless internet services to small and medium sized businesses. Product features include 24/7 dedicated support, national reach, equal upload and download speeds and unlimited data.
Invex Therapeutics a biopharmaceutical company focused on repurposing the use of Exenatide for efficacious treatment of neurological conditions derived from or involving raising intercranial pressure, such as idiopathic intracranial hypertension (IIH). There are currently no approved or efficacious treatments available for IIH patients. Invex Therapeutics listed on the ASX in July 2019.
Tattarang aims to deliver strong financial returns to support the work of Minderoo Foundation.
Minderoo Foundation is a modern philanthropic organisation that takes on tough, persistent issues with the potential to drive massive change. It incubates ideas and accelerates impact.
Minderoo Foundation is independent, forward thinking and seeks effective, scalable solutions. It is proudly Australian, and one of Asia’s largest philanthropic organisations.